"If you look at the overall costs of screening, the PSA test itself is very small," LeFevre said. "I'd be surprised to see them take what I call the political risk of backing away from that."
More information
For more on prostate cancer, visit the American Cancer Society.
Copyright © 2012 HealthDay. All rights reserved.
















Reader Comments Read all comments (2)